After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Most recently, Yahoo Finance reported about the stock as it publicized that PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of PTC Therapeutics Inc is $2.10B. A total of 0.62 million shares were traded on the day, compared to an average of 935.18K shares.
In the most recent transaction, Golden Lee Scott sold 526 shares of PTCT for 28.37 per share on Apr 02 ’24. After the transaction, the EVP & CHIEF MEDICAL OFFICER now owns 59,988 company shares. In a previous transaction on Jan 30 ’24, Boulding Mark Elliott sold 794 shares at 27.25 per share. PTCT shares that EXEC. VP AND CLO owns now total 71,189.
Among the insiders who sold shares, Almstead Neil Gregory disposed of 618 shares on Jan 30 ’24 at a per-share price of $27.25. This resulted in the CHIEF TECHNICAL OPS OFFICER holding 61,202 shares of PTCT after the transaction. In another insider transaction, Pauwels Eric sold 366 shares at $27.25 per share on Jan 30 ’24. Company shares held by the CHIEF BUSINESS OFFICER now total 44,181.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, PTCT has a high of $59.84 and a low of $17.53.
As of this writing, PTCT has an earnings estimate of -$1.25 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of -$0.56 per share and a lower estimate of -$1.93. The company reported an EPS of -$1.76 in the last quarter, which was -50.40% lower than expectations of -$1.17.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. PTCT’s latest balance sheet shows that the firm has $773.38M in Cash & Short Term Investments as of fiscal 2021. There were $535.38M in debt and $509.35M in liabilities at the time. Its Book Value Per Share was -$10.81, while its Total Shareholder’s Equity was $1.44M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PTCT is Buy with a score of 3.14.
